Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.
Authors
Barone, Martina
Ricci, Francesca
Sollazzo, Daria
Ottaviani, Emanuela
Romano, Marco
Auteri, Giuseppe
Reggiani, Maria LB
Vianelli, Nicola
Tazzari, Pier L
Cavo, Michele
Forte, Dorian
Palandri, Francesca
Publication Date
2019-06Journal Title
Br J Haematol
ISSN
0007-1048
Publisher
Wiley
Volume
185
Issue
5
Pages
987-991
Language
eng
Type
Article
This Version
AM
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Barone, M., Ricci, F., Sollazzo, D., Ottaviani, E., Romano, M., Auteri, G., Bartoletti, D., et al. (2019). Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis.. Br J Haematol, 185 (5), 987-991. https://doi.org/10.1111/bjh.15682
Keywords
Blood Platelets, Megakaryocytes, Humans, Pyrazoles, Female, Male, Janus Kinases, Primary Myelofibrosis
Sponsorship
Italian Association for Cancer Research (AIRC) (Fellowship Rif. 20930)
Medical Research Council (MC_PC_12009)
Identifiers
External DOI: https://doi.org/10.1111/bjh.15682
This record's URL: https://www.repository.cam.ac.uk/handle/1810/292422
Rights
All rights reserved
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.